Showing results (2051-2060 of 2,560) with videos related to

Sort By:
Pageof 256
The Journal of Urology|July 13, 2022
Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active SurveillanceChristopher P Filson, Kehao Zhu, Yijian Huang, et al.
The Prostate|March 23, 2021
Targeting backdoor androgen synthesis through AKR1C3 inhibition: A presurgical hormonal ablative neoadjuvant trial in high-risk localized prostate cancerLaura S Graham, Lawrence D True, Roman Gulati, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 30, 2008
Circulating microRNAs as stable blood-based markers for cancer detectionPatrick S Mitchell, Rachael K Parkin, Evan M Kroh, et al.
Zhonghua Shao Shang Za Zhi = Zhonghua Shaoshang Zazhi = Chinese Journal of Burns|July 2, 2018
[Experience of wound treatment on extremely severe mass burn patients involved in August 2nd Kunshan factory aluminum dust explosion accident]B M Shou, Q Tan, B W Sun, et al.
The Journal of Urology|April 30, 2025
Magnetic Resonance Imaging at Second Surveillance Biopsy After Diagnosis in Patients With Grade Group 1 Prostate Cancer in the Canary Prostate Active Surveillance StudyMeera R Chappidi, Lisa F Newcomb, Yingye Zheng, et al.
JAMA Oncology|July 25, 2024
BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A ReviewHeather H Cheng, Jeffrey W Shevach, Elena Castro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2007
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomyAndrew J Stephenson, Peter T Scardino, Michael W Kattan, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|August 6, 2018
[Clinical characteristics and antimicrobial resistance of pneumococcal infections from 9 children's hospitals in 2016]C Fang, X J Chen, M M Zhou, et al.
European Urology Oncology|March 24, 2024
Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or BicalutamideMamta Parikh, Catherine Tangen, Maha H A Hussain, et al.
JAMA|May 30, 2024
Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate CancerLisa F Newcomb, Jeannette M Schenk, Yingye Zheng, et al.
Pageof 256